Suchergebnisse - "Ang, Andrea Jing Shi"

PubPharm (5)

1

Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma : Does the sequence matter?

enthalten in: Asia-Pacific journal of clinical oncology | 2023

von Ng, K. | Wong, L. | Ang, A. | +7

2

Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma : Does the sequence matter?

enthalten in: Asia‐Pacific Journal of Clinical Oncology | 2023

von Ng, K. | Wong, L. | Ang, A. | +7

3

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma

enthalten in: Liver cancer | 2022

von Ng, K. | Tan, S. | Tan, J. | +7

4

Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma : Experience of a tertiary Asian Center

enthalten in: Asia-Pacific journal of clinical oncology | 2021

von Ng, K. | Wong, L. | Ang, A. | +4

CommentIn: Asia Pac J Clin Oncol. 2022 Aug;18(4):483. - PMID 34219387

5

Real‐world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma : Experience of a tertiary Asian Center

enthalten in: Asia‐Pacific Journal of Clinical Oncology | 2021

von Ng, K. | Wong, L. | Ang, A. | +4

1
[1]